DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $306,000 | -13.6% | 1,210 | 0.0% | 0.04% | +2.4% |
| Q1 2022 | $354,000 | -28.6% | 1,210 | -19.9% | 0.04% | -22.6% |
| Q4 2021 | $496,000 | -0.2% | 1,510 | -7.6% | 0.05% | -8.6% |
| Q3 2021 | $497,000 | +13.5% | 1,635 | 0.0% | 0.06% | +16.0% |
| Q2 2021 | $438,000 | +17.4% | 1,635 | -1.5% | 0.05% | +6.4% |
| Q1 2021 | $373,000 | +1.9% | 1,660 | +0.6% | 0.05% | -4.1% |
| Q4 2020 | $366,000 | -35.8% | 1,650 | -37.7% | 0.05% | -41.0% |
| Q3 2020 | $570,000 | +21.8% | 2,650 | 0.0% | 0.08% | +12.2% |
| Q2 2020 | $468,000 | +27.9% | 2,650 | 0.0% | 0.07% | +7.2% |
| Q1 2020 | $366,000 | -9.9% | 2,650 | 0.0% | 0.07% | +19.0% |
| Q4 2019 | $406,000 | +6.3% | 2,650 | 0.0% | 0.06% | +1.8% |
| Q3 2019 | $382,000 | +1.1% | 2,650 | 0.0% | 0.06% | +1.8% |
| Q2 2019 | $378,000 | -0.5% | 2,650 | -8.1% | 0.06% | -3.4% |
| Q1 2019 | $380,000 | +21.0% | 2,883 | -5.5% | 0.06% | +9.4% |
| Q4 2018 | $314,000 | -5.1% | 3,050 | 0.0% | 0.05% | +15.2% |
| Q3 2018 | $331,000 | +3.4% | 3,050 | -6.2% | 0.05% | 0.0% |
| Q2 2018 | $320,000 | +5.6% | 3,250 | +4.8% | 0.05% | +7.0% |
| Q1 2018 | $303,000 | +12.6% | 3,100 | +6.9% | 0.04% | +16.2% |
| Q4 2017 | $269,000 | +8.5% | 2,900 | 0.0% | 0.04% | +2.8% |
| Q3 2017 | $248,000 | +1.6% | 2,900 | 0.0% | 0.04% | 0.0% |
| Q2 2017 | $244,000 | -1.6% | 2,900 | 0.0% | 0.04% | -2.7% |
| Q1 2017 | $248,000 | -10.1% | 2,900 | -18.3% | 0.04% | -15.9% |
| Q4 2016 | $276,000 | -32.8% | 3,550 | -32.4% | 0.04% | -31.2% |
| Q3 2016 | $411,000 | -27.9% | 5,250 | -7.1% | 0.06% | -27.3% |
| Q2 2016 | $570,000 | -16.4% | 5,650 | -21.5% | 0.09% | -17.8% |
| Q1 2016 | $682,000 | +2.1% | 7,200 | 0.0% | 0.11% | +4.9% |
| Q4 2015 | $668,000 | +26.5% | 7,200 | +16.1% | 0.10% | +17.2% |
| Q3 2015 | $528,000 | +2.9% | 6,200 | +3.3% | 0.09% | +13.0% |
| Q2 2015 | $513,000 | +11.0% | 6,000 | +10.1% | 0.08% | +13.2% |
| Q1 2015 | $462,000 | +50.0% | 5,450 | +51.4% | 0.07% | +44.7% |
| Q4 2014 | $308,000 | – | 3,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |